Tumour-based MLH1 methylation testing was performed on all 10 sebaceous neoplasms identifying two MLH1 methylation positive samples, which were cross-validated by both MethyLight and MS-HRM assays (P-012 and P-019). Here, MLH1 is linked to sebaceous gland neoplasm.